Northern Trust’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Northern Trust’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,984	Closed	-$19.2K	–	4673
2023 Q1	$19.2K	Hold	11,984	–	–	﹤0.01%	4455
2022 Q4	$23.8K	Hold	11,984	–	–	﹤0.01%	4455
2022 Q3	$42K	Hold	11,984	–	–	﹤0.01%	4375
2022 Q2	$41K	Buy	11,984 +29	+0.2%	+$160	﹤0.01%	4466
2022 Q1	$109K	Buy	11,955 +4,135	+53%	+$62.8K	﹤0.01%	4320
2021 Q4	$168K	Sell	7,820 -29	-0.4%	-$776	﹤0.01%	4256
2021 Q3	$257K	Sell	7,849 -456	-5%	-$16.7K	﹤0.01%	4069
2021 Q2	$347K	Sell	8,305 -24,215	-74%	-$1.24M	﹤0.01%	3871
2021 Q1	$2.13M	Buy	32,520 +9,904	+44%	+$691K	﹤0.01%	3206
2020 Q4	$1.49M	Sell	22,616 -877	-4%	-$57.2K	﹤0.01%	3345
2020 Q3	$1.27M	Buy	23,493 +754	+3%	+$57.7K	﹤0.01%	3282
2020 Q2	$2.17M	Sell	22,739 -876	-4%	-$65.3K	﹤0.01%	3005
2020 Q1	$1.21M	Sell	23,615 -491	-2%	-$51.3K	﹤0.01%	3131
2019 Q4	$1.98M	Sell	24,106 -1,178	-5%	-$82.6K	﹤0.01%	3136
2019 Q3	$2.16M	Buy	25,284 +1,265	+5%	+$135K	﹤0.01%	3057
2019 Q2	$3.06M	Buy	24,019 +692	+3%	+$99.7K	﹤0.01%	2821
2019 Q1	$4.21M	Buy	23,327 +479	+2%	+$69.3K	﹤0.01%	2653
2018 Q4	$2.54M	Buy	22,848 +415	+2%	+$54.1K	﹤0.01%	2919
2018 Q3	$3.03M	Buy	22,433 +368	+2%	+$50.7K	﹤0.01%	2978
2018 Q2	$3.04M	Buy	22,065 +303	+1%	+$41.7K	﹤0.01%	2973
2018 Q1	$3M	Sell	21,762 -638	-3%	-$86.8K	﹤0.01%	2878
2017 Q4	$2.75M	Sell	22,400 -135	-0.6%	-$18.5K	﹤0.01%	2955
2017 Q3	$3.08M	Sell	22,535 -61	-0.3%	-$9.21K	﹤0.01%	2923
2017 Q2	$3.96M	Buy	22,596 +947	+4%	+$135K	﹤0.01%	2761
2017 Q1	$2.6M	Buy	21,649 +480	+2%	+$50K	﹤0.01%	2951
2016 Q4	$2.06M	Sell	21,169 -5,282	-20%	-$484K	﹤0.01%	3073
2016 Q3	$2.48M	Buy	26,451 +396	+2%	+$39.7K	﹤0.01%	2967
2016 Q2	$2.81M	Sell	26,055 -1,205	-4%	-$141K	﹤0.01%	2845
2016 Q1	$3.57M	Buy	27,260 +434	+2%	+$45.6K	﹤0.01%	2634
2015 Q4	$3.19M	Sell	26,826 -35	-0.1%	-$4.51K	﹤0.01%	2758
2015 Q3	$4.58M	Buy	26,861 +1,413	+6%	+$271K	﹤0.01%	2491
2015 Q2	$4.93M	Sell	25,448 -296	-1%	-$54.9K	﹤0.01%	2524
2015 Q1	$3.81M	Buy	25,744 +119	+0.5%	+$18.1K	﹤0.01%	2682
2014 Q4	$4M	Sell	25,625 -836	-3%	-$120K	﹤0.01%	2650
2014 Q3	$3.79M	Buy	26,461 +4,721	+22%	+$684K	﹤0.01%	2691
2014 Q2	$2.84M	Sell	21,740 -8,480	-28%	-$1.08M	﹤0.01%	2878
2014 Q1	$3.7M	Buy	30,220 +4,491	+17%	+$487K	﹤0.01%	2755
2013 Q4	$2.73M	Buy	25,729 +276	+1%	+$26.8K	﹤0.01%	2965
2013 Q3	$2.86M	Sell	25,453 -542	-2%	-$61.5K	﹤0.01%	2880
2013 Q2	$2.93M	Buy	+25,995	New	+$3.18M	﹤0.01%	2747

Other funds holding SRGA

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust's SRGA Position: Q2 2023 in Review

Northern Trust sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 11,984 shares — an estimated $19.2K sold.

Northern Trust first reported a position in SRGA in Q2 2013 and held it in 40 quarters. The position peaked at $4.93M in Q2 2015. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

Northern Trust reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Northern Trust sold 11,984 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $19.2K.
Northern Trust first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 40 quarters.
Northern Trust's Surgalign Holdings, Inc. Common Stock position peaked at $4.93M in Q2 2015.
25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.